Hi to all. Ok, from the onset, let me tell you all that I am new to holding stock in this company. I had no idea that this company nor the product Nasodine existed. I came across it quite by accident when I watched a video featuring Mr. Peter Molloy (Executive Chairman) on H.C's Corporate Spotlight. I watched the video once, left it, and then felt compelled to watch it a number of times. I didn't know of Peter Molloy, but I sure did know about Betadine throat gargle. Who in Australia doesn't know of it!
Here is an excerpt from Google
"Peter Molloy transformed a hospital antiseptic into Betadine throat gargle in 1984, and it has gone on to become Australia's largest selling over-the-counter sore throat treatment." Now, from an investment point of view, I see this as one very good reason to get on board with
FIREBRICK PHARMA LIMITED and Nasodine
. It wasn't all roses for Betadine throat gargle in 1984. Here is the full excerpt.
"Peter Molloy transformed a hospital antiseptic into Betadine throat gargle in 1984, and it has gone on to become Australia's largest selling over-the-counter sore throat treatment —
but it never gained approval for sale in the US."Peter responded with the following.
"The American company behind it saw it really as a hospital antiseptic but I saw it as something that could treat sore throats for example," Mr Molloy said. A very gracious response indeed, but then onwards and upwards. Betadine throat gargle is now sold in Asia, Australia, New Zealand, the Middle East & Africa, and Europe. So he has seen setbacks before and knows how to deal with them. Having Peter as the Executive Chairman of FIREBRICK tells me that we are in good hands. The setback in September of 2023 did impact many investors, and it was quite an unusual setback to say the least. But Peters final comment on this is as follows.
"We are confident that a way forward will emerge for Nasodine and that we will rebound from this setback." and today in 2024 and heading into 2025, this is what they are doing. They are rebounding and finding ways forward, and I have no doubts that they will succeed, and so will we as investors.
When I invest in a company, I look into the company and it's products and goals, but what I place my faith in is the leaders within that company. I feel safe under the careful guidance of Peter Molloy. I have read every single comment on every thread on HotCopper in regards to FIREBRICK. There has been the good, the bad and the ugly, but I see Peter replies to various comments, and he comes across as a very genuine person. I can hear the excitement in his voice going forward, all the while acknowledging any bumps we have encountered along the way. We have a fantastic opportunity going forward, and yes, I see this as a long term investment, not one for quick pips. I will be here for well into the next decade and possibly beyond, as it is not everyday we come across a great product with a great team heading it up.
For those that haven't, please watch the Corporate Spotlight video, and also, and review the following presentation again... maybe two or three times.
From the 25th Of September 2024.
https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2024/10/01202750/firebrick_pharma_investor_update-1080p.mp4For all Shareholders, management and staff of FIREBRICK, I wish for us all to have a happy and prosperous 2025, and I hope that the company has many successes going forward, wherein we will as well. I think our future looks bright.
I agree that Peter, Stephen and the team at Firebrick are doing a great job and I am also confident that we are going to see a great 2025 and beyond
